Macrophage IKKα Deficiency Suppresses Akt Phosphorylation, Reduces Cell Survival, and Decreases Early Atherosclerosis

Vladimir R Babaev1, Lei Ding2, Youmin Zhang2

  • 1From the Atherosclerosis Research Unit, Department of Medicine (V.R.B., L.D., Y.Z., J.M.M., M.R.F.L.) and Pharmacology (M.R.F.L.), Vanderbilt University Medical Center, Nashville, TN; Center for Cancer Research, National Cancer Institute, Frederick, MD (P.C.L.); and Department of Medicine, Center of Preventive Cardiology, Oregon Health & Science University, Portland, OR (S.F.). vladimir.babaev@vanderbilt.edu macrae.linton@vanderbilt.edu.

Abstract

Insights

Genetic deficiency of IKKα (inhibitor of κB kinase alpha) in macrophages impairs Akt signaling, reducing monocyte and macrophage survival and decreasing early atherosclerosis development.

Area of Science:

  • Cellular biology
  • Immunology
  • Molecular biology

Background:

  • The IκB kinase (IKK) complex regulates transcription factor cascades crucial for cellular responses.
  • IKKα is linked to prosurvival pathways like PI3K/Akt, but its specific role in cell survival and atherosclerosis is unclear.
  • Macrophages are key players in atherosclerosis pathogenesis.

Purpose of the Study:

  • To investigate the role of IKKα signaling in macrophage survival and its impact on atherogenesis.
  • To elucidate the molecular mechanisms by which IKKα influences macrophage response to lipotoxicity and apoptosis.

Main Methods:

  • Utilized genetic IKKα deficiency and pharmacological IKK inhibition in mouse macrophages.
  • Assessed Akt S(473) phosphorylation, mTOR complex 2 signaling, and apoptosis resistance in IKKα-deficient macrophages.
  • Evaluated atherosclerosis progression in low-density lipoprotein receptor (LDLR)(-/-) mice reconstituted with IKKα(-/-) hematopoietic cells.

Main Results:

  • Genetic IKKα deficiency reduced Akt S(473) phosphorylation and mTOR complex 2 signaling in macrophages.
  • IKKα-null macrophages showed impaired Akt signaling and reduced resistance to apoptosis, especially under lipotoxic conditions.
  • In vivo, IKKα deficiency led to increased macrophage apoptosis in atherosclerotic lesions and reduced early atherosclerosis in LDLR(-/-) mice.

Conclusions:

  • Hematopoietic IKKα deficiency suppresses Akt signaling in monocytes and macrophages.
  • This suppression compromises monocyte/macrophage survival.
  • Reduced monocyte/macrophage survival due to IKKα deficiency leads to decreased early atherosclerosis.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.2K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
13.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
10.3K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
9.2K